A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...

Every second counts in the Intensive Care Unit (ICU), with changes in patient status potentially occurring quickly and with no prior warning. Around-the-clock blood testing capabilities are essential ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...

Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...

Point of care devices within the healthcare system can aid in improving diagnoses as well as the control of diseases through monitoring. These devices can include glucose monitors that only require a ...

The global point of care testing market is projected to grow from USD 42 billion in 2025 to USD 64.8 billion by 2031, ...